ZA201202492B - Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity - Google Patents
Compounds for treating disorders or diseases associated with neurokinin 2 receptor activityInfo
- Publication number
- ZA201202492B ZA201202492B ZA2012/02492A ZA201202492A ZA201202492B ZA 201202492 B ZA201202492 B ZA 201202492B ZA 2012/02492 A ZA2012/02492 A ZA 2012/02492A ZA 201202492 A ZA201202492 A ZA 201202492A ZA 201202492 B ZA201202492 B ZA 201202492B
- Authority
- ZA
- South Africa
- Prior art keywords
- neurokinin
- compounds
- diseases associated
- receptor activity
- treating disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/003—Esters of saturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24001409P | 2009-09-04 | 2009-09-04 | |
| PCT/US2010/048006 WO2011029099A1 (en) | 2009-09-04 | 2010-09-07 | Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201202492B true ZA201202492B (en) | 2013-02-27 |
Family
ID=43649685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2012/02492A ZA201202492B (en) | 2009-09-04 | 2012-04-04 | Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120190743A1 (enExample) |
| EP (1) | EP2473038A4 (enExample) |
| JP (1) | JP2013503908A (enExample) |
| KR (1) | KR20120081120A (enExample) |
| CN (1) | CN102740693A (enExample) |
| AU (1) | AU2010289276A1 (enExample) |
| BR (1) | BR112012004988A2 (enExample) |
| CA (1) | CA2773035A1 (enExample) |
| MX (1) | MX2012002551A (enExample) |
| NZ (1) | NZ599215A (enExample) |
| RU (1) | RU2012112943A (enExample) |
| SG (1) | SG178964A1 (enExample) |
| WO (1) | WO2011029099A1 (enExample) |
| ZA (1) | ZA201202492B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508180A1 (en) * | 2011-04-04 | 2012-10-10 | Nestec S.A. | Sn-1(3) Monoacylglycerides and lipid absorption |
| EP3027199B1 (en) | 2013-08-01 | 2019-06-26 | Dignify Therapeutics, LLC | Compositions and methods for inducing urinary voiding and defecation |
| GB201315846D0 (en) | 2013-09-05 | 2013-10-23 | Imp Innovations Ltd | Method for treating or preventing hot flushes |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1001A (en) * | 1838-11-09 | Open grate fobj burning coai | ||
| GB820954A (en) * | 1956-05-02 | 1959-09-30 | Beecham Res Lab | Improvements in or relating to esters of 2,3-dimercaptopropanol |
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| JPS505309A (enExample) * | 1973-05-28 | 1975-01-21 | ||
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| JPH02131418A (ja) * | 1988-11-10 | 1990-05-21 | Sansho Seiyaku Co Ltd | 外用剤 |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| DE4204151A1 (de) * | 1992-02-12 | 1993-08-19 | Schneider Manfred Prof Dr | Regioisomerenreine monoglyceride sowie ein verfahren zu ihrer herstellung durch enzymatische veresterung von glycerin in organischen loesungsmitteln |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| JPH0931020A (ja) * | 1995-07-25 | 1997-02-04 | Soda Koryo Kk | グリセロールモノ−６−ヒドロキシアルカン酸エステル、及びこれを含有する香料組成物 |
| SE9604582D0 (sv) * | 1996-12-13 | 1996-12-13 | Astra Ab | Novel compounds |
| CN100528829C (zh) * | 1999-11-18 | 2009-08-19 | R·L·佩德森 | 信息素或其成分的复分解合成 |
| MY141736A (en) * | 2002-10-08 | 2010-06-15 | Elanco Animal Health Ireland | Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists |
| JO2676B1 (en) * | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
| CN1286529C (zh) * | 2004-06-11 | 2006-11-29 | 华中科技大学 | 具有皮肤靶向性的药物组合物及其制备方法和用途 |
| US7906147B2 (en) * | 2006-10-12 | 2011-03-15 | Nanoprobes, Inc. | Functional associative coatings for nanoparticles |
| JP2011509262A (ja) * | 2008-01-11 | 2011-03-24 | ユナイテッド パラゴン アソシエイツ インコーポレイテッド | 受精卵分離物およびその使用 |
-
2010
- 2010-09-07 KR KR1020127008768A patent/KR20120081120A/ko not_active Withdrawn
- 2010-09-07 NZ NZ599215A patent/NZ599215A/en not_active IP Right Cessation
- 2010-09-07 SG SG2012015046A patent/SG178964A1/en unknown
- 2010-09-07 CN CN2010800501768A patent/CN102740693A/zh active Pending
- 2010-09-07 JP JP2012528118A patent/JP2013503908A/ja active Pending
- 2010-09-07 US US13/394,067 patent/US20120190743A1/en not_active Abandoned
- 2010-09-07 WO PCT/US2010/048006 patent/WO2011029099A1/en not_active Ceased
- 2010-09-07 MX MX2012002551A patent/MX2012002551A/es not_active Application Discontinuation
- 2010-09-07 EP EP10814632.5A patent/EP2473038A4/en not_active Withdrawn
- 2010-09-07 RU RU2012112943/04A patent/RU2012112943A/ru not_active Application Discontinuation
- 2010-09-07 BR BR112012004988A patent/BR112012004988A2/pt not_active Application Discontinuation
- 2010-09-07 AU AU2010289276A patent/AU2010289276A1/en not_active Abandoned
- 2010-09-07 CA CA2773035A patent/CA2773035A1/en not_active Abandoned
-
2012
- 2012-04-04 ZA ZA2012/02492A patent/ZA201202492B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012004988A2 (pt) | 2015-09-08 |
| EP2473038A4 (en) | 2013-10-23 |
| MX2012002551A (es) | 2012-09-07 |
| RU2012112943A (ru) | 2013-10-10 |
| NZ599215A (en) | 2014-11-28 |
| SG178964A1 (en) | 2012-04-27 |
| JP2013503908A (ja) | 2013-02-04 |
| CA2773035A1 (en) | 2011-03-10 |
| AU2010289276A1 (en) | 2012-05-03 |
| CN102740693A (zh) | 2012-10-17 |
| WO2011029099A1 (en) | 2011-03-10 |
| EP2473038A1 (en) | 2012-07-11 |
| KR20120081120A (ko) | 2012-07-18 |
| US20120190743A1 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL212404A0 (en) | Compounds for treating ophthalmic diseases and disorders | |
| IL241791A0 (en) | Historical use of 3,1-diphenylprop-2-en-1-one for the treatment of liver disorders | |
| GB2467710B (en) | Methods for treating social disorders | |
| ZA201102640B (en) | Use of scyllo-inositols for the treatment of macular degeneration-related disorders | |
| PT2432798E (pt) | Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)- dieno-11-arilo, métodos para a sua produção e sua utilização para o tratamento de doenças | |
| GB0915259D0 (en) | Sulphur-linked compounds for treating ophthalmic diseases and disorders | |
| ZA201107449B (en) | Compounds for the treatment of metabolic disorders | |
| ZA201202346B (en) | Therapeutic agent for mood disorders | |
| ZA201107446B (en) | Compounds for the treatment of metabolic disorders | |
| GB0904284D0 (en) | Compounds for the treatment of metabolic disorders | |
| PL1982178T3 (pl) | Sposoby leczenia zaburzeń afektywnych | |
| EP2255825A4 (en) | COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES | |
| ZA201009226B (en) | Nifurtimox for treating disease caused by trichomonadida | |
| ZA201202492B (en) | Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity | |
| EP2387402A4 (en) | METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS WITH 2,4-PYRIMIDINIAMIN COMPOUNDS | |
| IL209417A0 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders | |
| IL207906A0 (en) | Treatment for ocular-related disorders | |
| EP2387565A4 (en) | 2,4-PYRIMIDINDIAMIN COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| EP2578206A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE LOWER PART OF THE UROGENITAL SYSTEM | |
| EP2240024A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
| HU0900722D0 (en) | Compounds for the treatment of neurological disorders | |
| GB0904288D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB0904289D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB0904290D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB0904286D0 (en) | Compounds for the treatment of metabolic disorders |